Application of Mesenchymal Stem Cell for Degenerative Disc Disease
DOI:
https://doi.org/10.58344/jws.v3i3.562Keywords:
Aplication, Degenerative Disc Disease, Mesenchymal Stem CellAbstract
During a person's life, the spine will experience continuous changes in response to physiological axial loads. Increasing age is also a cause of pathological degenerative changes. Degenerative disease of the spine is a condition that many people complain about and requires appropriate and effective treatment. Degenerative disc disease is the most common cause of low back pain and disability worldwide, involving people of all ages and socioeconomic statuses. This study aims to explain and analyze the effectiveness of Mesenchymal Stem Cell therapy in treating Degenerative Disc Disease. The research method used is a case study where Mesenchymal Stem Cell therapy offers the potential to modify the natural recovery of Degenerative Disc Disease using stem cell-based technology. Case studies were carried out at the Vinski Regenerative Center clinic, on several patients. And the results are that stem cells have the potential to be an ideal non-surgical treatment for low back pain and degenerative disc disease, because of their ability to differentiate into various connective tissue cells and their ability to restore damaged tissue and the results of case studies have proven to tend to improve the condition. However, long-term clinical studies are still needed, specifically focusing on the safety and efficacy of stem cell therapy in degenerative disc disease.
References
Beall, D. P., Wagoner, D. D., Davis, T. T., Ganey, T., Yoon, E., Koenig, B. M., Witherby, J., & Temple, H. T. (2020). New Biomaterials for Degenerative Disc Disease. The Disc and Degenerative Disc Disease: Remove or Regenerate?, 273–309.
Bogduk, N. (2022). On understanding the validity of diagnostic tests. Interventional Pain Medicine, 1, 100127.
Cannata, F., Vadalà, G., Ambrosio, L., Fallucca, S., Napoli, N., Papalia, R., Pozzilli, P., & Denaro, V. (2020). Intervertebral disc degeneration: a focus on obesity and type 2 diabetes. Diabetes/Metabolism Research and Reviews, 36(1), e3224.
Cao, G., Yang, S., Cao, J., Tan, Z., Wu, L., Dong, F., Ding, W., & Zhang, F. (2022). The role of oxidative stress in intervertebral disc degeneration. Oxidative Medicine and Cellular Longevity, 2022.
Chou, R., Côté, P., Randhawa, K., Torres, P., Yu, H., Nordin, M., Hurwitz, E. L., Haldeman, S., & Cedraschi, C. (2018). The Global Spine Care Initiative: applying evidence-based guidelines on the non-invasive management of back and neck pain to low-and middle-income communities. European Spine Journal, 27, 851–860.
Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., Ferreira, P. H., Fritz, J. M., Koes, B. W., & Peul, W. (2018). Prevention and treatment of low back pain: evidence, challenges, and promising directions. The Lancet, 391(10137), 2368–2383.
Kim, J.-W., Jeon, N., Shin, D.-E., Lee, S.-Y., Kim, M., Han, D. H., Shin, J. Y., & Lee, S. (2021). Regeneration in spinal disease: therapeutic role of hypoxia-inducible factor-1 alpha in regeneration of degenerative intervertebral disc. International Journal of Molecular Sciences, 22(10), 5281.
Kirnaz, S., Capadona, C., Lintz, M., Kim, B., Yerden, R., Goldberg, J. L., Medary, B., Sommer, F., McGrath, L. B., & Bonassar, L. J. (2021). Pathomechanism and biomechanics of degenerative disc disease: features of healthy and degenerated discs. International Journal of Spine Surgery, 15(s1), 10–25.
Kirnaz, S., Capadona, C., Wong, T., Goldberg, J. L., Medary, B., Sommer, F., McGrath Jr, L. B., & Härtl, R. (2022). Fundamentals of intervertebral disc degeneration. World Neurosurgery, 157, 264–273.
Lee, B.-C., & Kang, K.-S. (2020). Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application. Stem Cell Research & Therapy, 11, 1–10.
Li, B., Yang, Y., Wang, L., & Liu, G. (2021). Stem cell therapy and exercise for treatment of intervertebral disc degeneration. Stem Cells International, 2021.
Lyu, F.-J., Cui, H., Pan, H., Mc Cheung, K., Cao, X., Iatridis, J. C., & Zheng, Z. (2021). Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions. Bone Research, 9(1), 7.
NINDS. (2024). National Institute of Neurological Disorders and Stroke. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/back-pain
Rajesh, N., Moudgil-Joshi, J., & Kaliaperumal, C. (2022). Smoking and degenerative spinal disease: A systematic review. Brain and Spine, 2, 100916.
Samadi, P., Saki, S., Manoochehri, H., & Sheykhhasan, M. (2021). Therapeutic applications of mesenchymal stem cells:: a comprehensive review. Current Stem Cell Research & Therapy, 16(3), 323–353.
Scarcia, L., Pileggi, M., Camilli, A., Romi, A., Bartolo, A., Giubbolini, F., Valente, I., Garignano, G., D’Argento, F., & Pedicelli, A. (2022). Degenerative disc disease of the spine: from anatomy to pathophysiology and radiological appearance, with morphological and functional considerations. Journal of Personalized Medicine, 12(11), 1810.
Soufi, K. H., Castillo, J. A., Rogdriguez, F. Y., DeMesa, C. J., & Ebinu, J. O. (2023). Potential role for stem cell regenerative therapy as a treatment for degenerative disc disease and low back pain: a systematic review. International Journal of Molecular Sciences, 24(10), 8893.
Thailand, R. C. of. (2024). Can stem cells help reverse degenerative disc disease? Stem Cell Regeneration Center. Stemcellthailand.Org. https://stemcellthailand.org/therapies/degenerative-disc-disease-ddd/
Wangler, S., Kamali, A., Wapp, C., Wuertz-Kozak, K., Häckel, S., Fortes, C., Benneker, L. M., Haglund, L., Richards, R. G., & Alini, M. (2021). Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic, and degenerative intervertebral discs: a proteomic analysis. Stem Cell Research & Therapy, 12, 1–17.
Wong, J. J., Côté, P., Sutton, D. A., Randhawa, K., Yu, H., Varatharajan, S., Goldgrub, R., Nordin, M., Gross, D. P., & Shearer, H. M. (2017). Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. European Journal of Pain, 21(2), 201–216.
Xia, Y., Yang, R., Hou, Y., Wang, H., Li, Y., Zhu, J., & Fu, C. (2022). Application of mesenchymal stem cell-derived exosomes from different sources in intervertebral disc degeneration. Frontiers in Bioengineering and Biotechnology, 10, 1019437.
Xie, G., Liang, C., Yu, H., & Zhang, Q. (2021). Association between polymorphisms of collagen genes and susceptibility to intervertebral disc degeneration: a meta-analysis. Journal of Orthopaedic Surgery and Research, 16, 1–13.
Xin, J., Wang, Y., Zheng, Z., Wang, S., Na, S., & Zhang, S. (2022). Treatment of intervertebral disc degeneration. Orthopaedic Surgery, 14(7), 1271–1280.
Zehra, U., Tryfonidou, M., Iatridis, J. C., Illien-Jünger, S., Mwale, F., & Samartzis, D. (2022). Mechanisms and clinical implications of intervertebral disc calcification. Nature Reviews Rheumatology, 18(6), 352–362.
Zhang, W., Sun, T., Li, Y., Yang, M., Zhao, Y., Liu, J., & Li, Z. (2022). Application of stem cells in the repair of intervertebral disc degeneration. Stem Cell Research & Therapy, 13(1), 70.
Zielinska, N., Podgórski, M., Ha?adaj, R., Polguj, M., & Olewnik, ?. (2021). Risk factors of intervertebral disc pathology—A point of view formerly and today—A review. Journal of Clinical Medicine, 10(3), 409.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of World Science
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.